HEADER IMMUNE SYSTEM,HYDROLASE INHIBITOR 18-DEC-06 2OAY TITLE CRYSTAL STRUCTURE OF LATENT HUMAN C1-INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMA PROTEASE C1 INHIBITOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SERPIN DOMAIN; COMPND 5 SYNONYM: C1-INHIBITOR; C1 INH; C1INH; C1 ESTERASE INHIBITOR; C1- COMPND 6 INHIBITING FACTOR; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SERPING1, C1IN, C1NH; SOURCE 6 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: GS115; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPIC9K KEYWDS LATENT SERPIN; RCL INSERTION, IMMUNE SYSTEM, HYDROLASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR V.HARMAT,L.BEINROHR,P.GAL,J.DOBO REVDAT 7 30-AUG-23 2OAY 1 HETSYN REVDAT 6 29-JUL-20 2OAY 1 COMPND REMARK SEQADV HETNAM REVDAT 6 2 1 LINK SITE REVDAT 5 18-OCT-17 2OAY 1 REMARK REVDAT 4 13-JUL-11 2OAY 1 VERSN REVDAT 3 24-FEB-09 2OAY 1 VERSN REVDAT 2 07-AUG-07 2OAY 1 JRNL REVDAT 1 01-MAY-07 2OAY 0 JRNL AUTH L.BEINROHR,V.HARMAT,J.DOBO,Z.LORINCZ,P.GAL,P.ZAVODSZKY JRNL TITL C1 INHIBITOR SERPIN DOMAIN STRUCTURE REVEALS THE LIKELY JRNL TITL 2 MECHANISM OF HEPARIN POTENTIATION AND CONFORMATIONAL DISEASE JRNL REF J.BIOL.CHEM. V. 282 21100 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17488724 JRNL DOI 10.1074/JBC.M700841200 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 84.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 20803 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1125 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.41 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1546 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2270 REMARK 3 BIN FREE R VALUE SET COUNT : 78 REMARK 3 BIN FREE R VALUE : 0.3200 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2845 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 70 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 32.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.29000 REMARK 3 B22 (A**2) : 0.29000 REMARK 3 B33 (A**2) : -0.43000 REMARK 3 B12 (A**2) : 0.14000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.239 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.197 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.154 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.574 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2952 ; 0.020 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2693 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4015 ; 1.764 ; 1.967 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6265 ; 0.804 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 370 ; 7.479 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 481 ; 0.098 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3204 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 558 ; 0.005 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 599 ; 0.216 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3056 ; 0.256 ; 0.300 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 1927 ; 0.100 ; 0.500 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 148 ; 0.187 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 13 ; 0.273 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): 45 ; 0.390 ; 0.300 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 9 ; 0.186 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1852 ; 2.070 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3006 ; 3.238 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1100 ; 2.123 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1006 ; 3.367 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 101 A 476 REMARK 3 RESIDUE RANGE : A 500 A 500 REMARK 3 ORIGIN FOR THE GROUP (A): -14.7946 71.6738 -0.6784 REMARK 3 T TENSOR REMARK 3 T11: 0.1060 T22: 0.0380 REMARK 3 T33: 0.1121 T12: 0.0229 REMARK 3 T13: -0.0025 T23: 0.0519 REMARK 3 L TENSOR REMARK 3 L11: 1.5314 L22: 2.5613 REMARK 3 L33: 2.8210 L12: 0.1233 REMARK 3 L13: 0.1272 L23: 1.5387 REMARK 3 S TENSOR REMARK 3 S11: -0.0220 S12: -0.0272 S13: 0.0470 REMARK 3 S21: -0.0132 S22: -0.0308 S23: -0.0146 REMARK 3 S31: -0.1414 S32: -0.2032 S33: 0.0528 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2OAY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000040907. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8162 REMARK 200 MONOCHROMATOR : SI [111] REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21930 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 84.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 14.60 REMARK 200 R MERGE (I) : 0.09700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.2900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.54 REMARK 200 R MERGE FOR SHELL (I) : 0.65200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.890 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: ENSEMBLE OF TRUNCATED SERPIN STRUCTURES. PDB REMARK 200 CODES: 4CAA, 1QMB, 1E05, 1DVM, 1C8O, 1JTI, 1JJO, 1MTP, 1HLE, 1JRR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.85 M NAH2PO4, 0.85 M KH2PO4, 0.1 M REMARK 280 HEPES, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.12267 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 31.56133 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 47.34200 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 15.78067 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 78.90333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 89 REMARK 465 VAL A 90 REMARK 465 HIS A 91 REMARK 465 HIS A 92 REMARK 465 HIS A 93 REMARK 465 HIS A 94 REMARK 465 HIS A 95 REMARK 465 HIS A 96 REMARK 465 THR A 97 REMARK 465 GLY A 98 REMARK 465 SER A 99 REMARK 465 PHE A 100 REMARK 465 GLY A 103 REMARK 465 PRO A 104 REMARK 465 MET A 138 REMARK 465 LYS A 139 REMARK 465 LYS A 140 REMARK 465 VAL A 141 REMARK 465 LYS A 294 REMARK 465 ASN A 295 REMARK 465 ARG A 477 REMARK 465 ALA A 478 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 106 CB OG1 CG2 REMARK 470 LEU A 107 CG CD1 CD2 REMARK 470 GLU A 165 CG CD OE1 OE2 REMARK 470 LYS A 168 CE NZ REMARK 470 LYS A 179 CG CD CE NZ REMARK 470 GLU A 238 CG CD OE1 OE2 REMARK 470 SER A 261 OG REMARK 470 LYS A 276 NZ REMARK 470 LYS A 278 CD CE NZ REMARK 470 LYS A 285 CE NZ REMARK 470 ARG A 287 CD NE CZ NH1 NH2 REMARK 470 SER A 296 CB OG REMARK 470 LYS A 306 CE NZ REMARK 470 LYS A 307 CD CE NZ REMARK 470 GLN A 316 CD OE1 NE2 REMARK 470 LYS A 319 CE NZ REMARK 470 LYS A 342 CG CD CE NZ REMARK 470 LYS A 368 CG CD CE NZ REMARK 470 ASP A 413 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O THR A 193 O HOH A 18 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 184 CB - CA - C ANGL. DEV. = -13.9 DEGREES REMARK 500 ASP A 212 CB - CG - OD2 ANGL. DEV. = 6.8 DEGREES REMARK 500 ASP A 234 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 LEU A 456 CA - CB - CG ANGL. DEV. = 16.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 106 79.90 65.40 REMARK 500 PHE A 396 -82.89 -87.06 REMARK 500 LEU A 405 43.66 -108.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP A 180 PHE A 181 -147.98 REMARK 500 REMARK 500 REMARK: NULL DBREF 2OAY A 97 478 UNP P05155 IC1_HUMAN 119 500 SEQADV 2OAY TYR A 89 UNP P05155 EXPRESSION TAG SEQADV 2OAY VAL A 90 UNP P05155 EXPRESSION TAG SEQADV 2OAY HIS A 91 UNP P05155 EXPRESSION TAG SEQADV 2OAY HIS A 92 UNP P05155 EXPRESSION TAG SEQADV 2OAY HIS A 93 UNP P05155 EXPRESSION TAG SEQADV 2OAY HIS A 94 UNP P05155 EXPRESSION TAG SEQADV 2OAY HIS A 95 UNP P05155 EXPRESSION TAG SEQADV 2OAY HIS A 96 UNP P05155 EXPRESSION TAG SEQADV 2OAY MET A 458 UNP P05155 VAL 480 VARIANT SEQRES 1 A 390 TYR VAL HIS HIS HIS HIS HIS HIS THR GLY SER PHE CYS SEQRES 2 A 390 PRO GLY PRO VAL THR LEU CYS SER ASP LEU GLU SER HIS SEQRES 3 A 390 SER THR GLU ALA VAL LEU GLY ASP ALA LEU VAL ASP PHE SEQRES 4 A 390 SER LEU LYS LEU TYR HIS ALA PHE SER ALA MET LYS LYS SEQRES 5 A 390 VAL GLU THR ASN MET ALA PHE SER PRO PHE SER ILE ALA SEQRES 6 A 390 SER LEU LEU THR GLN VAL LEU LEU GLY ALA GLY GLU ASN SEQRES 7 A 390 THR LYS THR ASN LEU GLU SER ILE LEU SER TYR PRO LYS SEQRES 8 A 390 ASP PHE THR CYS VAL HIS GLN ALA LEU LYS GLY PHE THR SEQRES 9 A 390 THR LYS GLY VAL THR SER VAL SER GLN ILE PHE HIS SER SEQRES 10 A 390 PRO ASP LEU ALA ILE ARG ASP THR PHE VAL ASN ALA SER SEQRES 11 A 390 ARG THR LEU TYR SER SER SER PRO ARG VAL LEU SER ASN SEQRES 12 A 390 ASN SER ASP ALA ASN LEU GLU LEU ILE ASN THR TRP VAL SEQRES 13 A 390 ALA LYS ASN THR ASN ASN LYS ILE SER ARG LEU LEU ASP SEQRES 14 A 390 SER LEU PRO SER ASP THR ARG LEU VAL LEU LEU ASN ALA SEQRES 15 A 390 ILE TYR LEU SER ALA LYS TRP LYS THR THR PHE ASP PRO SEQRES 16 A 390 LYS LYS THR ARG MET GLU PRO PHE HIS PHE LYS ASN SER SEQRES 17 A 390 VAL ILE LYS VAL PRO MET MET ASN SER LYS LYS TYR PRO SEQRES 18 A 390 VAL ALA HIS PHE ILE ASP GLN THR LEU LYS ALA LYS VAL SEQRES 19 A 390 GLY GLN LEU GLN LEU SER HIS ASN LEU SER LEU VAL ILE SEQRES 20 A 390 LEU VAL PRO GLN ASN LEU LYS HIS ARG LEU GLU ASP MET SEQRES 21 A 390 GLU GLN ALA LEU SER PRO SER VAL PHE LYS ALA ILE MET SEQRES 22 A 390 GLU LYS LEU GLU MET SER LYS PHE GLN PRO THR LEU LEU SEQRES 23 A 390 THR LEU PRO ARG ILE LYS VAL THR THR SER GLN ASP MET SEQRES 24 A 390 LEU SER ILE MET GLU LYS LEU GLU PHE PHE ASP PHE SER SEQRES 25 A 390 TYR ASP LEU ASN LEU CYS GLY LEU THR GLU ASP PRO ASP SEQRES 26 A 390 LEU GLN VAL SER ALA MET GLN HIS GLN THR VAL LEU GLU SEQRES 27 A 390 LEU THR GLU THR GLY VAL GLU ALA ALA ALA ALA SER ALA SEQRES 28 A 390 ILE SER VAL ALA ARG THR LEU LEU VAL PHE GLU VAL GLN SEQRES 29 A 390 GLN PRO PHE LEU PHE MET LEU TRP ASP GLN GLN HIS LYS SEQRES 30 A 390 PHE PRO VAL PHE MET GLY ARG VAL TYR ASP PRO ARG ALA MODRES 2OAY ASN A 216 ASN GLYCOSYLATION SITE HET NAG A 500 14 HET GOL A5001 6 HET GOL A5002 6 HET GOL A5003 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 NAG C8 H15 N O6 FORMUL 3 GOL 3(C3 H8 O3) FORMUL 6 HOH *70(H2 O) HELIX 1 1 GLU A 112 SER A 136 1 25 HELIX 2 2 SER A 148 GLY A 162 1 15 HELIX 3 3 GLY A 164 SER A 176 1 13 HELIX 4 4 CYS A 183 GLY A 190 1 8 HELIX 5 5 ARG A 211 SER A 223 1 13 HELIX 6 6 ASN A 232 ASN A 247 1 16 HELIX 7 7 ARG A 344 LEU A 352 1 9 HELIX 8 8 SER A 353 MET A 366 1 14 HELIX 9 9 MET A 387 GLU A 392 1 6 HELIX 10 10 LYS A 393 GLU A 395 5 3 HELIX 11 11 ASP A 398 LEU A 403 5 6 SHEET 1 A 7 MET A 145 PHE A 147 0 SHEET 2 A 7 PHE A 466 VAL A 473 -1 O MET A 470 N PHE A 147 SHEET 3 A 7 PHE A 455 ASP A 461 -1 N PHE A 455 O VAL A 473 SHEET 4 A 7 LEU A 331 PRO A 338 -1 N SER A 332 O TRP A 460 SHEET 5 A 7 ALA A 320 GLN A 326 -1 N LYS A 321 O VAL A 337 SHEET 6 A 7 ILE A 298 ASP A 315 -1 N PHE A 313 O VAL A 322 SHEET 7 A 7 ARG A 287 PHE A 291 -1 N GLU A 289 O VAL A 300 SHEET 1 B 7 MET A 145 PHE A 147 0 SHEET 2 B 7 PHE A 466 VAL A 473 -1 O MET A 470 N PHE A 147 SHEET 3 B 7 PHE A 455 ASP A 461 -1 N PHE A 455 O VAL A 473 SHEET 4 B 7 LEU A 331 PRO A 338 -1 N SER A 332 O TRP A 460 SHEET 5 B 7 ALA A 320 GLN A 326 -1 N LYS A 321 O VAL A 337 SHEET 6 B 7 ILE A 298 ASP A 315 -1 N PHE A 313 O VAL A 322 SHEET 7 B 7 PHE A 369 PRO A 377 -1 O LEU A 374 N SER A 305 SHEET 1 C 7 ARG A 227 VAL A 228 0 SHEET 2 C 7 VAL A 196 HIS A 204 1 N ILE A 202 O ARG A 227 SHEET 3 C 7 LEU A 265 LYS A 276 -1 O TYR A 272 N THR A 197 SHEET 4 C 7 GLY A 431 ILE A 440 -1 O ALA A 436 N ILE A 271 SHEET 5 C 7 MET A 419 LEU A 427 -1 N VAL A 424 O ALA A 435 SHEET 6 C 7 LYS A 380 ASP A 386 -1 N VAL A 381 O LEU A 425 SHEET 7 C 7 LEU A 446 VAL A 448 -1 O VAL A 448 N THR A 382 SSBOND 1 CYS A 101 CYS A 406 1555 1555 2.02 SSBOND 2 CYS A 108 CYS A 183 1555 1555 2.05 LINK ND2 ASN A 216 C1 NAG A 500 1555 1555 1.46 CRYST1 98.903 98.903 94.684 90.00 90.00 120.00 P 65 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010111 0.005838 0.000000 0.00000 SCALE2 0.000000 0.011675 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010561 0.00000